Johnson & Johnson works in the Netherlands with more than 4,000 employees in two sectors: Johnson & Johnson Innovative Medicine (formerly known as “Janssen”) and Johnson & Johnson MedTech.
Janssen has been part of the Johnson & Johnson family since 1961. Our focus is oncology, immunology, neuroscience, cardiovascular diseases, pulmonary hypertension, and eye disorders.
We innovate every day in all areas of our business to remain at the forefront of prevention, treatment, and cure of these conditions. For example, in Leiden, we are working on a new vaccine against nosocomial infections, and we produce and test biologics on a global scale. We also prepare cell- and gene-technology in our new production facility in Sassenheim. With our organization in Breda, we ensure that our medicines become available to doctors and patients in the Netherlands.
Johnson & Johnson MedTech innovates at the intersection of biology and technology. At Johnson & Johnson MedTech, we also work to solve the most pressing challenges in healthcare. We mainly focus on surgery, orthopedics, and eye care. With our innovations at the intersection of biology and technology, we are developing the next generation of smarter, less invasive treatments tailored to the patient.
We are situated in Leiden, where we produce breast implants. In our Groningen and Eindhoven facilities, we deliver leading vision technologies and products. And from our Amersfoort organization, we serve Dutch hospitals with our medical technology products and services.
Please visit https://www.janssen.com/netherlands/nl for more information.
Contact person: Eliane Lauwers, [email protected]
Recente reacties